Market Movers (8-K)
See all →NYSE
BlueLinx Holdings Inc. held its 2026 Annual Meeting, re-electing most directors, ratifying auditor appointment, approving executive compensation advisory vote, and amending the long-term incentive plan, while a director's resignation offer was rejected.
NYSE
BlueLinx Holdings Inc. announced its first quarter 2026 financial results, reporting a 3.1% increase in net sales to $731 million, alongside a net loss of $1.5 million.
NYSE
BlueLinx Holdings Inc. announced a net loss of $(8.6) million for Q4 2025 and a significant drop in full-year net income to $0.2 million, despite slight sales growth and strong free cash flow.
Worse than expected
NYSE
BlueLinx Holdings Inc. has amended its bylaws to implement majority voting for directors in uncontested elections and a director resignation policy.
NYSE
BlueLinx Holdings Inc. announced the planned retirement of Chief Commercial Officer Michael Wilson and the appointment of Leo Oei as his successor, effective January 5, 2026.
NYSE
BlueLinx Holdings Inc. reports a significant drop in net income and adjusted EBITDA for Q3 2025, despite a slight increase in net sales and a strategic acquisition.
Worse than expected
Quarterly Earnings (10-Q)
See all →NYSE
BlueLinx Holdings reported a net loss for the first quarter of fiscal 2026, with increased net sales driven by specialty products, while structural products saw a decline.
Worse than expected
NYSE
BlueLinx Holdings Inc. reported a significant drop in net income and diluted EPS for Q3 2025 and the first nine months, primarily due to competitive pricing, increased interest expense, and import duty adjustments.
Capital raise
Worse than expected
NYSE
BlueLinx Holdings Inc. announced a significant drop in net income and operating cash flow for the second quarter and first half of fiscal 2025, driven by competitive pricing, increased operating expenses, and higher interest costs.
Worse than expected
NYSE
BlueLinx Holdings Inc. reports a decrease in net income for the first quarter of 2025, impacted by lower specialty product sales and gross margin compression.
Worse than expected
NYSE
10-Q: BlueLinx Holdings Inc. Reports Third Quarter 2024 Results: Sales Decline Amid Pricing Pressures
BlueLinx Holdings Inc. experienced a decrease in net sales and gross profit for the third quarter of 2024, primarily due to pricing pressures in both specialty and structural product categories.
Worse than expected
NYSE
BlueLinx Holdings Inc. reported a decrease in net sales and net income for the second quarter of 2024, primarily due to demand challenges in the housing and building product sectors and declining lumber prices.
Worse than expected
Annual Reports (10-K)
NYSE
BlueLinx Holdings Inc. reports a significant decline in net income and gross profit for fiscal 2025 despite a slight increase in net sales, driven by strategic acquisition and volume growth offset by pricing pressures.
Worse than expected
Delay expected
NYSE
BlueLinx Holdings Inc.'s 2024 annual report reveals a decrease in net sales offset by strategic capital allocation and share repurchases.
Worse than expected
NYSE
BlueLinx Holdings Inc.'s 10-K filing details the company's share structure, governance policies, and risk factors, providing investors with a comprehensive overview of the company's operations and potential challenges.
Worse than expected
Insider Trading (Form 4)
See all →NYSE
Kim S Fennebresque, a Director of BlueLinx Holdings Inc., sold 34,138 shares of common stock on August 6, 2026 for $84.15 per share.
NYSE
Chief Commercial Officer Leonard Alexander Oei reported the vesting of restricted stock units and the receipt of new equity grants in a recent SEC Form 4 filing.
NYSE
Kimberly Ann DeBrock, VP & Chief Accounting Officer of BlueLinx Holdings Inc., reported the vesting of restricted stock units and a new equity grant.
NYSE
BlueLinx Holdings Inc. CFO Christopher K. Wall reported the vesting of restricted stock units and the acquisition of new equity grants.
NYSE
Shyam K. Reddy, President and CEO of BlueLinx Holdings Inc., reported a series of transactions involving the acquisition and disposition of company common stock.
NYSE
BlueLinx Holdings Inc. SVP, CFO and Treasurer Christopher K. Wall reported transactions involving restricted stock units and common stock.
Proxy Statements (Def-14A)
NYSE
BlueLinx Holdings Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, executive compensation, and an amendment to its long-term incentive plan.
NYSE
BlueLinx Holdings Inc. will hold its 2025 Annual Meeting of Stockholders on May 15, 2025, to elect directors, ratify the appointment of Ernst & Young LLP, and approve executive compensation.
NYSE
BlueLinx Holdings Inc. will hold its 2024 Annual Meeting of Stockholders on May 16, 2024, to elect directors, ratify the appointment of Ernst & Young LLP, and approve executive compensation.
Schedule 13G - Passive Investments
See all →NYSE
Vanguard Capital Management has reported a 4.94% ownership stake in BlueLinx Holdings Inc. as of June 30, 2026.
NYSE
Tontine Asset Associates and Jeffrey L. Gendell have reported a 9.4% beneficial ownership stake in BlueLinx Holdings Inc.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.2% of BlueLinx Holdings Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in BlueLinx Holdings Inc. following an internal realignment.
NYSE
SCHEDULE 13G/A: BlackRock Boosts BlueLinx Holdings Stake to 11.8%
BlackRock, Inc. has disclosed an 11.8% beneficial ownership stake in BlueLinx Holdings Inc., holding 926,837 shares of common stock.
NYSE
SCHEDULE 13G/A: Tontine Entities Boost BlueLinx Holdings Stake
Tontine Asset Associates, Tontine Capital Overseas Master Fund II, and Jeffrey L. Gendell collectively report an 8.4% beneficial ownership stake in BlueLinx Holdings Inc.